Sign in
CompletedNo phase

Effect of Norepinephrine Administration on Ventricular Systolic Function in Septic Shock

Key facts

Who runs it
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Where
Italy1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
30 people enrolled
Started
10 Mar 2022
Ended
20 May 2024
Type of study
Observational
Record updated
21 May 2024

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (8)Hide the full registry criteria

Who can take part

  • less than 6 hours from the diagnosis of septic shock
  • ongoing vasopressor therapy by continuous intravenous infusion of norepinephrine
  • treating physician's decision to increase norepinephrine dose

Who cannot take part

  • myocardial disfunction due to active cardiac disease
  • preload responsiveness assessed through dynamic indices
  • pregnancy
  • inadequate acoustic window for transthoracic echocardiography
  • need for emergency treatment

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This observational, pharmacological, prospective study aims to assess the improvement of ventricular systolic function mediated by norepinephrine (NE) administration in preload non-responders septic shock patients. Left ventricular outflow tract velocity time integral (LVOT-VTI) is an echocardiographic index of ventricular systolic function and it will be measured at different NE dosages.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effect of NorEpinephrine Administration on Ventricular Systolic Function in Septic Shock Patients: the ENESySS Study
Record updated
21 May 2024